echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Finland's research and development of nasal spray new crown medicament obtained patent

    Finland's research and development of nasal spray new crown medicament obtained patent

    • Last Update: 2021-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Finland's research and development of nasal spray new crown medicament obtained patent
    Finnish research and development of nasal spray new crown medicament obtains patent Finnish research and development of nasal spray new crown medicament obtains patent

    Xinhua News Agency, Helsinki, May 24 (Reporter Chen Jing and Xu Qian) According to a report by the Finnish National Broadcasting Corporation on the 24th, a new nasal spray new crown drug developed by Therapeutica Borealis, a Finnish pharmaceutical company, has obtained a patent authorization from the US Patent and Trademark Office.


    According to reports, this nasal spray contains active ingredients such as aprotinin, hydroxychloroquine and ivermectin.


    The company said, “The active substances used in the new drugs are well-known and commonly used drugs, but in the present invention, these active substances are used in the upper respiratory tract mucosa in a new targeted way.


    In a telephone interview with Xinhua News Agency, the main developer of the new drug, Carlylvo Vernell, said that because the principle of the nasal spray is to target the human body rather than the virus, the mutant virus has little effect on its efficacy.


    aspx?id=3570" target="_blank" style="color:#ba1413">Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.